IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(1.11) per share which missed the analyst consensus estimate of $(0.98) by 13.27 percent. This is a 35.37 percent decrease over losses of $(0.82) per share from the same period last year. The company reported quarterly sales of $6.560 million which beat the analyst consensus estimate of $5.008 million by 31.00 percent.